Total Payments
$402,555
2024 Payments
$145,928
Companies
57
Transactions
928
Medicare Patients
3,694
Medicare Billing
$732,719
Payment Breakdown by Category
Other$306,600 (76.2%)
Consulting$41,027 (10.2%)
Travel$36,701 (9.1%)
Food & Beverage$18,024 (4.5%)
Education$135.08 (0.0%)
Gifts$68.27 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $239,625 | 76 | 59.5% |
| Honoraria | $65,700 | 27 | 16.3% |
| Consulting Fee | $41,027 | 24 | 10.2% |
| Travel and Lodging | $36,701 | 117 | 9.1% |
| Food and Beverage | $18,024 | 673 | 4.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,275 | 1 | 0.3% |
| Education | $135.08 | 5 | 0.0% |
| Gift | $68.27 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $193,168 | 225 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $102,448 | 125 | $0 (2024) |
| Avadel CNS Pharmaceuticals, LLC | $73,575 | 79 | $0 (2024) |
| Axsome Therapeutics, Inc. | $24,270 | 35 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $1,774 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $978.52 | 66 | $0 (2024) |
| Biogen, Inc. | $578.59 | 35 | $0 (2024) |
| ABBVIE INC. | $461.88 | 26 | $0 (2024) |
| PFIZER INC. | $458.67 | 40 | $0 (2024) |
| UCB, Inc. | $415.96 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145,928 | 246 | Avadel CNS Pharmaceuticals, LLC ($63,773) |
| 2023 | $134,586 | 175 | JAZZ PHARMACEUTICALS INC. ($79,178) |
| 2022 | $107,652 | 182 | Harmony Biosciences LLC ($55,726) |
| 2021 | $9,843 | 50 | HARMONY BIOSCIENCES LLC ($8,220) |
| 2020 | $563.92 | 30 | Teva Pharmaceuticals USA, Inc. ($149.45) |
| 2019 | $1,200 | 79 | Novartis Pharmaceuticals Corporation ($250.66) |
| 2018 | $994.79 | 69 | Novartis Pharmaceuticals Corporation ($118.10) |
| 2017 | $1,787 | 97 | Jazz Pharmaceuticals Inc. ($276.52) |
All Payment Transactions
928 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: PAIN | ||||||
| 12/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Insomnia | ||||||
| 12/16/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/03/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Neurology | ||||||
| 12/03/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Pain Management | ||||||
| 12/03/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $5.60 | General |
| Category: Narcoplepsy | ||||||
| 11/27/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $1,600.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/26/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Immunology | ||||||
| 11/26/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: PAIN | ||||||
| 11/26/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $2,800.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/21/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/20/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Rare Disease | ||||||
| 11/05/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Pain Management | ||||||
| 11/04/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 917 | 1,101 | $2.3M | $191,575 |
| 2022 | 12 | 926 | 1,225 | $1.7M | $175,868 |
| 2021 | 12 | 880 | 1,185 | $1.7M | $181,754 |
| 2020 | 12 | 971 | 1,298 | $1.8M | $183,523 |
Total Patients
3,694
Total Services
4,809
Medicare Billing
$732,719
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 121 | 121 | $1.1M | $63,316 | 5.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 92 | 93 | $846,300 | $51,345 | 6.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 231 | 323 | $52,425 | $28,153 | 53.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 188 | 256 | $67,687 | $16,365 | 24.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 19 | 31 | $160,995 | $11,827 | 7.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $19,641 | $9,976 | 50.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 45 | $6,884 | $4,880 | 70.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $11,518 | $2,038 | 17.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 24 | $1,863 | $1,461 | 78.4% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 33 | 35 | $2,253 | $964.16 | 42.8% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2023 | 32 | 34 | $1,913 | $961.93 | 50.3% |
| G0451 | Development testing, with interpretation and report, per standardized instrument form | Office | 2023 | 31 | 33 | $990.00 | $285.90 | 28.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 71 | 72 | $644,400 | $39,296 | 6.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 64 | 66 | $600,600 | $37,940 | 6.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 281 | 442 | $53,021 | $36,386 | 68.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 28 | 56 | $303,022 | $22,823 | 7.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 168 | 244 | $73,440 | $16,623 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 83 | 83 | $14,834 | $10,166 | 68.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 44 | 46 | $6,802 | $4,763 | 70.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $12,350 | $2,431 | 19.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 40 | $3,090 | $2,320 | 75.1% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2022 | 46 | 50 | $2,239 | $1,362 | 60.8% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2022 | 46 | 50 | $2,239 | $1,335 | 59.6% |
| G0451 | Development testing, with interpretation and report, per standardized instrument form | Office | 2022 | 46 | 50 | $1,500 | $423.40 | 28.2% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 87 | 89 | $796,700 | $50,045 | 6.3% |
About Dr. Matthew Davis, MD
Dr. Matthew Davis, MD is a Sleep Medicine healthcare provider based in Middletown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1629238860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Davis, MD has received a total of $402,555 in payments from pharmaceutical and medical device companies, with $145,928 received in 2024. These payments were reported across 928 transactions from 57 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($239,625).
As a Medicare-enrolled provider, Davis has provided services to 3,694 Medicare beneficiaries, totaling 4,809 services with total Medicare billing of $732,719. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Neurology
- Location Middletown, NJ
- Active Since 06/11/2008
- Last Updated 10/26/2023
- Taxonomy Code 2084S0012X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629238860
Products in Payments
- XYWAV (Drug) $189,840
- LUMRYZ (Drug) $73,575
- Wakix (Drug) $63,988
- WAKIX (Drug) $38,460
- Sunosi (Drug) $24,202
- SUNOSI (Drug) $2,582
- QUVIVIQ (Drug) $1,774
- NURTEC ODT (Drug) $605.87
- TYSABRI (Biological) $437.65
- Xyrem (Drug) $363.61
- KESIMPTA (Drug) $361.38
- XYREM (Drug) $358.99
- Briviact (Drug) $323.99
- QULIPTA (Drug) $318.43
- RYTARY (Drug) $238.17
- OCREVUS (Biological) $223.76
- MAYZENT (Drug) $217.09
- AIMOVIG (Biological) $202.42
- GILENYA (Drug) $166.69
- APTIOM (Drug) $160.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.